David Brenneman, a Harvard-trained lawyer who crossed into finance and was an executive director in equity risk management at Morgan Stanley, has died. He was 37.
He died on Aug. 31 at Memorial Sloan-Kettering Cancer Center in Manhattan following a 16-month battle with leiomyosarcoma, or LMS, a rare cancer of the soft tissue, according to his wife, Mina Brenneman. A father of three, he was a resident of Chappaqua and stopped working only in mid-July when he had his final surgery, his wife said.
At Morgan Stanley, owner of the world's largest brokerage, Brenneman specialized in prime brokerage and worked at the firm's Manhattan headquarters in Times Square, spokesman Mark Lake said.
Brenneman jumped to finance after starting his career in another demanding field, law.
"After the birth of his first son, he couldn't stand the hours anymore," Mina Brenneman said in an interview. "He went from 80 hours a week to 60 hours a week. We thought that was a vast improvement."
In April, about 200 Morgan Stanley colleagues attended the annual fundraising gala of the Sarcoma Foundation of America to see Brenneman receive the group's Courage Award for "strength and perseverance" in battling the disease. He raised hundreds of thousands of dollars toward sarcoma research.
"Over the past year, I really can say that Morgan Stanley has become part of my treatment process, part of my recovery, a second family to me," Brenneman told the gathering, according to a home video that his brother, Michael, posted on YouTube. "I couldn't imagine going through this without such a supportive group of colleagues, such a generous group of colleagues."
With his wife, the former Mina Nedialkova, whom he met at Yale in 1998, Brenneman had three children -- sons William, 8, and Alexander, 6; and daughter Margaret, 3.
In addition to his parents, wife, children and brother, survivors include a second brother, Matt Brenneman.